Ramirez, Reysa A.
HRN: 12-27-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2024
CEFUROXIME 1.5GM (VIAL)
05/25/2024
06/01/2024
IVT
1.5g
Q8
S/P Primary LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes